The company had reported net profit of Rs 262.11 crore in the January-March quarter of financial year 2012-13.
Cadila's net sales in the quarter under review were up by 22.40 per cent to Rs 1,916.33 crore as against Rs 1,565.53 crore in the year-ago period, the company said in a BSE filing.
During the quarter, the company recorded tax expense of Rs 34.76 crore as against a tax credit of Rs 59.02 crore in the corresponding period a year ago.
Overall expenses in Q4 stood at Rs 1,662.73 crore, up 21.11 per cent, compared with Rs 1,372.81 crore in the same quarter of last fiscal.
Cadila Healthcare scrips were trading at Rs 911 apiece in the afternoon trade, down 3.11 per cent from its previous close on the BSE.